Potential inhibition of 12- < em > O < /em > -tetradecanoylphorbol-13-acetate-induced inflammation, hyperproliferation, and hyperplasiogenic responses by celecoxib in mouse skin
CONCLUSION: Our results demonstrate that topical celecoxib can reduce the inflammation, hyperproliferation, and hyperplasiogenic events of skin insults suggesting that it may prove to be a valuable management option for cutaneous lesion and associated illnesses such as atopic dermatitis, eczema, and psoriasis, as well as the emergence of non-melanoma cancer.PMID:38127818 | DOI:10.1080/15569527.2023.2295843
Source: Cutaneous and Ocular Toxicology - Category: Toxicology Authors: Shakilur Rahman Rizwanul Haque Sheikh Raisuddin Source Type: research
More News: Cancer | Cancer & Oncology | Celebrex | Dermatitis | Dermatology | Eczema | Melanoma | Nonmelanoma Skin Cancer | Psoriasis | Skin | Skin Cancer | Study | Switzerland Health | Toxicology